Change language dansk English suomi svenska

Generate Estimates Confirm Cancel Hide empty rows Show hidden rows DummyText

MEDICSPORT A/S Estimate generation in progress, please wait... 0%

Quicksearch from your own companies XBRLDenmark Analyst: XBRLDenmark

Loading... Loading... Loading... Loading...   Loading...

1000.0 Bankruptcy Risk  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Bankruptcy risk for industry   1.5% 1.5% 1.5% 1.5% 1.5% 1.5% 2.4% 2.4%   Bankruptcy risk   4.9% 2.8% 5.9% 2.6% 4.5% 3.4% 7.2% 7.0%   Credit score (0-100)   46 61 39 60 46 53 34 34   Credit rating   BBB BBB BBB BBB BBB BBB BBB BBB   Credit limit (kDKK)   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   How are these values calculated?   View the automatically generated explanation of bankruptcy risk 1000.0 Income statement (kDKK)  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Net sales   0 0 0 0 0 0 0 0   Gross profit   11,162 15,744 10,905 12,092 29,470 28,997 0.0 0.0   EBITDA   -457 1,382 -2,249 1,565 -4,440 1,226 0.0 0.0   EBIT   -989 1,382 -2,249 1,565 -5,409 279 0.0 0.0   Pre-tax profit (PTP)   -1,586.0 504.0 -1,697.0 633.0 -7,383.0 -1,738.8 0.0 0.0   Net earnings   -1,239.0 504.0 -1,697.0 633.0 -5,861.0 -1,397.8 0.0 0.0   Pre-tax profit without non-rec. items   -1,586 1,382 -2,249 1,565 -7,383 -1,739 0.0 0.0     See the entire income statement 1000.0 Balance sheet (kDKK)  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Tangible assets total   1,012 0.0 0.0 0.0 2,381 1,731 0.0 0.0   Shareholders equity total   6,656 9,400 7,323 8,336 20,469 18,907 16,907 16,907   Interest-bearing liabilities   10,638 0.0 0.0 0.0 38,050 39,425 0.0 0.0   Balance sheet total (assets)   31,279 38,583 37,837 42,541 112,177 98,654 16,907 16,907   Net Debt   10,638 0.0 0.0 0.0 37,660 39,358 -16,907 -16,907     See the entire balance sheet 1000.0 Volume  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Net sales   0 0 0 0 0 0 0 0   Net sales growth   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Gross profit   11,162 15,744 10,905 12,092 29,470 28,997 0.0 0.0   Gross profit growth   31.1% 41.0% -30.7% 10.9% 143.7% -1.6% -100.0% 0.0%   Employees   35 42 28 26 62 51 0 0   Employee growth %   25.0% 20.0% -33.3% -7.1% 138.5% -17.7% -100.0% 0.0%   Employee expenses   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Balance sheet total (assets)   31,279 38,583 37,837 42,541 112,177 98,654 16,907 16,907   Balance sheet change%   -19.1% 23.4% -1.9% 12.4% 163.7% -12.1% -82.9% 0.0%   Added value   -457.0 1,382.0 -2,249.0 1,565.0 -5,409.0 1,226.1 0.0 0.0   Added value %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Investments   -495 -1,012 0 0 1,412 -1,597 -1,731 0   Net sales trend   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   EBIT trend   -2.0 1.0 -1.0 1.0 -1.0 1.0 0.0 0.0   1000.0 Profitability  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A EBITDA %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   EBIT %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   EBIT to gross profit (%)   -8.9% 8.8% -20.6% 12.9% -18.4% 1.0% 0.0% 0.0%   Net Earnings %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Profit before depreciation and extraordinary items %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Pre tax profit less extraordinaries %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   ROA %   -2.4% 4.0% -5.9% 3.9% -5.7% 2.7% 0.0% 0.0%   ROI %   -4.7% 4.9% -5.9% 3.9% -8.6% 4.8% 0.0% 0.0%   ROE %   -17.3% 6.3% -20.3% 8.1% -40.7% -7.1% 0.0% 0.0%   1000.0 Solidity  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Equity ratio %   22.2% 100.0% 100.0% 100.0% 18.4% 19.2% 100.0% 100.0%   Relative indebtedness %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Relative net indebtedness %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Net int. bear. debt to EBITDA, %   -2,327.8% 0.0% 0.0% 0.0% -848.2% 3,210.0% 0.0% 0.0%   Gearing %   159.8% 0.0% 0.0% 0.0% 185.9% 208.5% 0.0% 0.0%   Net interest   0 0 0 0 0 0 0 0   Financing costs %   7.1% 0.0% 0.0% 0.0% 15.5% 11.9% 0.0% 0.0%   1000.0 Liquidity  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Quick Ratio   0.8 0.0 0.0 0.0 0.5 0.7 0.0 0.0   Current Ratio   1.2 0.0 0.0 0.0 1.4 1.4 0.0 0.0   Cash and cash equivalent   0.0 0.0 0.0 0.0 390.0 67.0 0.0 0.0   1000.0 Capital use efficiency  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Trade debtors turnover (days)   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Trade creditors turnover (days)   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Current assets / Net sales %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Net working capital   4,305.0 0.0 0.0 0.0 28,904.0 25,297.8 0.0 0.0   Net working capital %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   1000.0 Employee efficiency  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Net sales / employee   0 0 0 0 0 0 0 0   Added value / employee   -13 33 -80 60 -87 24 0 0   Employee expenses / employee   0 0 0 0 0 0 0 0   EBITDA / employee   -13 33 -80 60 -72 24 0 0   EBIT / employee   -28 33 -80 60 -87 5 0 0   Net earnings / employee   -35 12 -61 24 -95 -27 0 0